STO, in collaboration with various partners in China, extends its reach and commitment to providing global programs that present the latest and best cancer research while fostering best practices.

Advanced Clinical Trials (ACT) China
These workshops feature presentations and discussions that provide insights into the essential elements of clinical trial excellence.

STO-CSCO International Fellowship Program
Chinese Society of Clinical Oncology (CSCO) and Society for Translational Oncology (STO) collectively value the importance of innovative and professional career development for young Chinese oncologists. Through strategic relationships with world-class institutions, sharing clinical programs, and collaborative research projects, the International Fellowship Program (IFP) is designed to address China’s pressing need for more oncologists with advanced clinical skills.

STO-CSCO Joint Symposium 
STO-CSCO Joint Symposium focuses on clinical advances in immuno-oncology and offers new experiences and insights on the clinical application of immunotherapy. It is led by an outstanding faculty who contextualize the educational content for clinical application and provide a foundational but comprehensive understanding of immunology. In 2022 and onward, this Symposium undertakes a comparative analysis of the regulatory requirements for the proper conduction of cancer clinical trials with an aim to harmonize both the high standards needed for cancer clinical trial design, as well as the rigor applied to cancer drug evaluation and approval.